We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Biogen (NASDAQ: BIIB) has had a rocky few years. Its multiple sclerosis franchise has been bleeding market share to generics and biosimilars, revenue has trended down, and the stock spent much of 2025 trading near multi-year lows. So when Goldman Sachs steps up with a price target hike to $250, ...
We recently compiled a list of the 8 Most Oversold Large Cap Stocks to Buy. Insulet Corporation (NASDAQ:PODD) is one of the most oversold stocks. TheFly reported on May 7 that PODD saw its valuation outlook revised as Goldman Sachs reduced its price target to $237 from $277 while maintaining a Buy rating on the […]
Wall Street delivered a split verdict on Uber Technologies (NYSE:UBER) following the company’s Q1 2026 earnings report on May 6. Goldman Sachs (NYSE:GS) lowered its price target to $115 from $125 while maintaining a Buy rating, and Piper Sandler (NYSE:PIPR) analyst Thomas Champion raised his target to $105 from $100 while keeping an Overweight rating. ... Wall Street Splits on Uber: Goldman Sachs Cuts Price Target While Piper Sandler Hikes